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Cyclin-dependent kinases (Cdks) and their cyclin regulatory subunits control cell growth and division. Cdk2-cyclin E
complexes, phosphorylating the retinoblastoma protein, drive cells through the G1/S transition into the S phase of
the cell cycle. Despite its fundamental role, Cdk2 was found to be indispensable only in specific cell types due to
molecular redundancies in its function. Converging studies highlight involvement of Cdk2 and associated cell cycle
regulatory proteins in oligodendrocyte progenitor cell proliferation and differentiation. Giving the contribution of
this immature cell type to brain plasticity and repair in the adult, this review will explore the requirement of Cdk2
for oligodendrogenesis, oligodendrocyte progenitor cells proliferation and differentiation during physiological and
pathological conditions.
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During development, the majority of oligodendrocyte pro-
genitor cells (OPCs) undergo a limited period of prolifera-
tion, before cell cycle exit and terminal differentiation into
postmitotic myelinating oligodendrocytes [1]. However, a
population of slowly dividing OPCs persists throughout the
adult CNS [2-4] and there is growing interest concerning
the signals influencing proliferation and differentiation of
these progenitors [5]. Adult OPCs share common features
with perinatal OPCs such as the expression of NG2 and
PDGFRα and the ability to differentiate into oligodendro-
cytes but also astrocytes and neurons [4,6-11]. However,
their cell cycle length and rate of differentiation are slower
comparing with perinatal OPCs. They exhibit precise prolif-
erative capacity defined as intrinsic timer concept with each
cell dividing invariably 8 times in culture before exiting the
cell cycle and differentiating [1,12]. Moreover, despite their
low oligodendrogenic potential under physiological condi-
tions, adult OPCs can be reactivated in terms of prolifera-
tion, migration and differentiation leading to remyelination* Correspondence: anne.baron@upmc.fr
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use, distribution, and reproduction in any medafter CNS white matter insults [4,13-15]. Therefore they are
considered as major targets for therapeutical strategies.
OPCs can also be generated from the subventricular zone
(SVZ) in the adult forebrain both under physiological con-
ditions [16,17] and after demyelination in rodents and
human brain [18-21]. After demyelination of the adult
brain, SVZ-derived OPCs are recruited to the lesions and
contribute to periventricular remyelination [22,23]. All
these specificities make the study of the cell cycle regulation
in this cell type of great interest.
Cell proliferation is a key phenomenon during develop-
ment and repair. It is regulated by complex extrinsic and
intrinsic mechanisms involving cyclin-dependent kinases
(Cdks), a family of serine/threonine kinases that represents
the core of the cell cycle machinery. Successive waves of
Cdk activity control initiation and progression through the
eukaryotic cell cycle in response to both intra-cellular and
extra-cellular signals (Figure 1). During early G1 phase,
the retinoblastoma protein Rb acts as a negative regulator
of the cell cycle through its ability to sequester the tran-
scription factor E2F. Later, its phosphorylation initiated by
Cdk4/6 and completed by Cdk2 - activated upon specific
binding of the D and E cyclins, respectively [24] - irrevers-
ibly inactivates Rb. E2F transcription factor are going to
be released and translocate to the nucleus to promoteensee BioMed Central Ltd. This is an Open Access article distributed under the
icense (http://creativecommons.org/licenses/by/2.0), which permits unrestricted
ium, provided the original work is properly cited.
Figure 1 Control of cell cycle progression. Mitogenic signalling results in cyclin D synthesis, formation of active Cdk4/6-cyclin D complexes
and initial phosphorylation of Rb. Partially phosphorylated Rb still binds to transcription factor E2F but some genes can be transcribed, such as
cyclin E which binds to and activates Cdk2. It is generally accepted that Cdk2-dependent phosphorylation of Rb results in its complete
inactivation, which allows induction of the E2F-responsive genes that are needed to drive cells through the G1/S transition. R represents the
restriction point that separates the mitogen-dependent early G1 phase from the mitogen-independent late G1 phase. Cdk2 associated to cyclin A
controls progression through S phase. Cdk1-cyclin A complex is responsible for G2 phase progression. Cdk1 associated to cyclin B is essential for
both G2/M transition and mitosis progression.
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E cyclin. G1/S transition no longer depends on mitogen
factors: activity of Cdk2-cyclin E complexes enables to
reach the restriction point. Giving their key role in the
progression of the cell cycle, Cdk activity is tightly regu-
lated at different levels to fit to both intra-cellular and
extra-cellular signals. This regulation process includes
interactions with activating subunits (the cyclins), Cdk
inhibitors or Cdkis (INK4 and Cip/Kip family members),
phosphorylation-dephosphorylation, folding and subcellu-
lar localization. INK4 proteins (p16INK4a, p15INK4b,
p18INK4c and p19INK4d) specifically interact with Cdk4 and
Cdk6 and prevent their association with D cyclin. Cip/Kip
proteins (p21Cip1, p27Kip1 and p57Kip2) have a broader
spectrum of activity. Associated to Cdk2, they block its
kinase activity but, in return, Cdk2 associated kinase activ-
ity regulates the proteolysis of both its activator E cyclin
and its inhibitor p27Kip1 [25]. First observations demon-
strated the essential requirement of p21 and p27 in stoe-
chiometric proportions for the formation of Cdk4/6-cyclin
D complexes [25] but were not confirmed [26,27]. After
formation of Cdk4/6-cyclin D complexes in the cytoplasm
and import to the nucleus, these complexes are going to
sequester p27 from resident Cdk2/cyclin E/p27 complexes
allowing Cdk2 activation [28]. Expression of some Cdk
inhibitors can be directly or indirectly regulated by the
tumour suppressor p53. Because of the specificity of adult
OPCs cell cycle regulation and their reactivation potential,
several groups have investigated the links between cell cycleregulation and oligodendrocyte differentiation [1,12,29-36].
In this review, we discuss the specific role of Cdk2 as an im-
portant component of the mechanism that couples the
regulation of OPC proliferation and differentiation.
Differential requirement for Cdk2 in adult germinative
regions
Cdk2 is critical for proliferation and self-renewal of neural
progenitor cells in the adult subventricular zone
Adult oligodendrocytes can arise from either white matter
OPC or neural progenitor cells from the subventricular
zone (SVZ). Therefore a study investigated the function of
Cdk2 in the adult subventricular zone and more precisely
in chondroitin sulfate proteoglycan NG2-expressing pro-
genitors taking advantage of a viable Cdk2−/− mouse mu-
tant [37,38]. NG2+ cells from the SVZ display cellular
properties of transient-amplifying (type C) cells and are
able to generate oligodendrocytes in the adult [6,22]. Pro-
liferation of NG2+ cells was demonstrated to be selectively
impaired in the adult SVZ of mice lacking Cdk2 (Table 1).
Importantly, loss of Cdk2 did not affect proliferation of
slowly dividing GFAP+-nestin+ stem cells or PSA-NCAM+
neuroblasts [30,39] indicating that intrinsic cell cycle regu-
lators play distinct roles in different cell populations of the
adult SVZ. Analysis in cultures obtained from adult SVZ
NG2+ cells is consistent with the in vivo findings, as a sig-
nificant decrease in the formation of neurospheres was
also observed in Cdk2−/− cells [39]. Moreover, it appears
that Cdk2 might play a specific role in adult neural
Table 1 Differential influence of Cdk2 loss on OPC
Physiological condition Pathological condition
SVZ CC SVZ CC
Proliferation # NO # #
Differentiation " NO " "
Myelination/
remyelination
NC NO NC "
The pathological condition concerns corpus callosum LPC-induced
demyelination. SVZ subventricular zone; CC corpus callosum; NO not observed;
NC not concerned
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liferation of embryonic fibroblasts or human colon cancer
cell lines in culture [37,38,40].
The decrease in NG2+ cell proliferation observed in
the adult SVZ may result from a shift in balance be-
tween cell proliferation and differentiation and/or cell
death. Caspase-3+ apoptotic cells were quantified and no
differences were observed in cell death in the absence of
Cdk2 at P8 or P90. These results were confirmed by
quantification of TUNEL+ cells [39]. However, cellular
and molecular analyses in vivo and in vitro demonstrate
that the loss of Cdk2 promotes NG2+ cell lineage com-
mitment and differentiation in oligodendrocytes of adult
SVZ cells [39] (Table 1). Regarding these results, Cdk2
appears to contribute not only to cell cycle regulation
but also to the decision to differentiate. At variance with
findings in the adult SVZ, in vivo and in vitro analysis
demonstrated that both NG2+ cell proliferation and self-
renewal capacities were not affected by the loss of the
Cdk2 gene up to postnatal day 15 implying during peri-
natal period compensatory activity of other Cdks which
is a well known phenomenon [41]. Cdk1 could play this
role as in the absence of interphase Cdks (Cdk4, Cdk6
and Cdk2), it can execute all the events that are required
to drive mammalian cell division [42]. More precisely, in
p27−/−; Cdk2−/− double KO mice, Cdk1 compensates
the loss of Cdk2 function, binding to cyclin E and regu-
lating G1/S transition [37,43]. However, probably due to
the importance of the genetic locus for Cdk function
[44] in specific cell types, Cdk1 is unable to compensate
for the loss of Cdk2 in germinal cells as Cdk2−/− mice
are sterile [37,38]. In SVZ protein extracts from Cdk2
−/− P8 and P90 mice, Cdk1 expression was evaluated
and difference with wild-type mice could not be found.
Actually, compensatory mechanisms in perinatal Cdk2
−/− SVZ cells, which persist until postnatal day 15, in-
volve increased Cdk4 expression that results in retino-
blastoma protein inactivation [39]. A subsequent decline
in Cdk4 activity to wild-type levels in postnatal day 28
Cdk2−/− cells coincides with lower NG2+ proliferation
and self-renewal capacity similar to adult levels. Cdk4
compensation was confirmed by silencing experiments
in perinatal Cdk2−/− SVZ cells that abolishes Cdk4 up-regulation and reduces cell proliferation and self-renewal
to adult levels. Conversely, Cdk4 overexpression in adult
SVZ cells restores proliferative capacity to wild-type
levels [39]. Thus, although Cdk2 is functionally redun-
dant in perinatal SVZ, it is important for adult progeni-
tor cell proliferation and self-renewal, through age-
dependent regulation of Cdk4.
Cdk2 is dispensable for adult hippocampal neurogenesis
The subventricular zone does not constitute the only persis-
tant germinative zone in the adult as granule neurons
undergo continuous renewal throughout life in the dentate
gyrus (DG) of the hippocampus. Thus, the requirement of
Cdk2 has also been investigated in this region using Cdk2
deficient mice [45]. Surprisingly, the quantification of cell
cycle markers first revealed that the lack of Cdk2 activity
does not influence spontaneous or seizure-induced prolif-
eration of neural progenitor cells in the adult DG. Using
bromodeoxyuridine incorporation assays, it was shown that
the number of mature newborn granule neurons generated
de novo was similar in both wild-type and Cdk2-deficient
adult mice. Moreover, the apparent lack of cell output re-
duction in Cdk2−/− mice DG did not result from a reduc-
tion in apoptosis of newborn granule cells as analyzed by
TUNEL assays [45]. So, contrary to its role in NPC prolif-
eration in the adult SVZ, Cdk2 seems to be dispensable for
NPC proliferation, differentiation and survival of adult-born
DG granule neurons in vivo. This discrepancy could be
explained by compensatory mechanisms, which may be
region-specific and may reflect the low proliferative poten-
tial of hippocampal progenitors, as compared to their SVZ
counterpart. Alternatively, these differences may have
resulted from a non essential role played by Cdk2 in neuro-
genic regions of the brain, such as the adult hippocampus,
as compared to the SVZ, which is directly involved in oligo-
dendrogenesis, a process that more closely depends on the
control of OPC proliferation by Cdk2.
Influence of Cdk2 and related cell cycle proteins on OPC
Martin C. Raff was one of the first to identify integrated
sequential signals that control oligodendrocyte differenti-
ation. He postulated that a cell-intrinsic timer regulates
the onset of oligodendroglial differentiation based on a
model system in which the normal timing of oligodendro-
cyte development can be reconstituted in OPC cultures of
dissociated embryonic and perinatal optic nerve, as long
as OPCs are stimulated to divide by PDGF [35,46]. Indeed,
in these conditions, OPCs divided up to eight times before
they stopped and differentiated [1,12]. The question of
how the timer works is still unanswered but several candi-
date factors have been identified to be part of the molecu-
lar structure of this cell intrinsic timer and all the studies
converge to proteins involved in G1/S transition and espe-
cially Cdk2 [5].
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OPCs proliferation. Indeed, accumulation of p18INK4c in
OPCs was demonstrated to precede proliferation arrest
and its overexpression can prevent OPCs proliferation
induced by mitogens [47]. Actually, high levels of INK4
proteins inhibit the activity of Cdk4/6-cyclin D com-
plexes which can no more sequestrate Cip/Kip inhibitors
that are going to inhibit Cdk2-cyclin E complexes and
then induce OPCs cell cycle arrest.
Depending on the levels and modality of activation, the
tumor suppressor p53 can act as transcriptional activator
or repressor of many genes, causing apoptosis, cell cycle
arrest in G1 or G2/M, or differentiation depending on the
cell type [48]. In proliferating OPCs, p53 proteins are low
and the protein is likely not functional, because of its cyto-
plasmic localization [49]. Upon removal of mitogens, how-
ever, p53 is transiently translocated to the nucleus and
maybe involved in both growth arrest and the onset of
OPC differentiation by stimulating p21 expression and
consequently inhibition of Cdk2-cyclin E complexes [49].
Previous studies in vitro and in vivo indicated that
p27Kip1 and p21Cip1 that negatively regulate the activity of
the Cdk 4/6-cyclin D and Cdk2-cyclin E complexes [50],
are important regulators of OPC proliferation during de-
velopment [31,32,34,51-54]. The levels of these Cdkis in-
crease in OPCs either during permanent cell cycle
withdrawal and differentiation or during reversible cell
cycle arrest in G1 caused by neuronal signals [31,32,34,51-
54] (Figure 2). Regulation of G1 phase progression was
consequently supposed to be crucial for OPC prolifera-
tion. The increase in p27Kip1 protein levels observed dur-
ing OPC differentiation results in an enhancement of its
binding to the Cdk2-cyclin E complex and inhibition of
Cdk2 activity [54,55]. Ectopic expression of p27Kip1 in
OPCs causes a significant reduction in Cdk2-cyclin E ac-
tivity and cell cycle arrest [36,56]. Purified rat OPCs were
used to investigate the molecular mechanisms that regu-
late permanent cell cycle withdrawal and reversible arrest
in the oligodendrocyte lineage [33]. Higher protein levels
of cyclin E and D and Cdks 2, 4 and 6 and higher kinase
activities of both Cdk4/6-cyclin D and Cdk2-cyclin E were
found in proliferating OPCs compared to cells that had
permanently withdrawn from the cycle. This was asso-
ciated with a decrease in the formation of the Cdk2-cyclin
E and Cdk4/6-cyclin D complexes in differentiated oligo-
dendrocytes [33]. Reversible cell cycle arrest in G1
induced by glutamatergic and β-adrenergic receptor acti-
vation or cell depolarization, however, did not modify cyc-
lin E and Cdk2 protein expression compared with
proliferating OPCs. Instead, these agents caused a selective
decrease in Cdk2 activity and an impairment of Cdk2-
cyclin E complex formation. Although cyclin D protein
levels were higher than in proliferating cells, cyclin D-
associated kinase activity was not modified in G1-arrestedOPCs [33]. These results are consistent with analysis in
corpus callosum in vivo that showed that Cdk2-cyclin E
activity increased between postnatal days 3 and 15 and
decreased between postnatal days 15 and 30, during and
after terminal division and differentiation of immature oli-
godendrocytes [33]. These results indicate that the Cdk2-
cyclin E complex is a major regulator of OPC cycle pro-
gression and that the Cdks involved in reversible cell cycle
arrest are distinct from those implicated in permanent cell
cycle withdrawal. To establish a causal link between
Cdk2-cyclin E activity and OPC proliferation, Cdk2 activ-
ity was selectively modulated in vitro by transfection of
cultured OPCs [29]. Dominant-negative (Dn)-Cdk2 over-
expression inhibited mitogen-induced OPC proliferation,
whereas wild-type (WT)-Cdk2 prevented cell cycle arrest
caused by anti-mitotic signals. Therefore, in OPCs, cell
cycle pathways activated either in a pro- or in anti-mitotic
environment, converge on the common molecular target
Cdk2. Dn-Cdk2- or WT-Cdk2-mediated regulation of G1/
S transition, per se, did not influence initiation of OPC
differentiation.
In vitro studies demonstrated lineage continuity be-
tween perinatal and adult OPCs [8,11]. However, the mo-
lecular basis of their differences in cell proliferation and
cell cycle length are still unknown [57]. To study the func-
tion of Cdk2-cyclin E in OPCs during development
in vivo, Cdk2 and cyclin E expression were first analyzed
in cells acutely isolated from transgenic mice expressing
GFP under the control of CNP gene promoter. In these
transgenic mice, GFP is selectively expressed in the oligo-
dendroglial lineage throughout embryonic and postnatal
development [58,59]. Both Cdk2-cyclin E protein levels
and activity were found decreased in GFP+ oligodendro-
cyte lineage cells between postnatal days 4 and 30. Immu-
nostaining of NG2+/GFP+ OPCs in brain tissue sections
showed a 90% decrease in overall cell proliferation and
Cdk2 expression between perinatal and adult cells [29,30].
However, Cdk2 expression within the proliferating OPC
population was maintained throughout development. In-
trinsic differences in Cdk2-cyclin E expression and activity
may underlie the slowly proliferative state that charac-
terizes the so-called quiescent adult OPCs in vivo. Cdk2-
deficient mice were also analyzed to elucidate the func-
tional involvement of Cdk2 in OPC proliferation and oli-
godendrogenesis in vivo. Interestingly, loss of Cdk2 had
no effect on OPC proliferation and generation of oligo-
dendrocytes during early postnatal (P8) development and
in the adult (P90) corpus callosum [30]. Moreover, differ-
ences in density and distribution of cells representing dif-
ferent stages of oligodendrocyte development were not
observed in WT versus Cdk2−/− adult mice (P90). These
results suggest that, even if Cdk2 controls OPC prolifera-
tion, it is not required for normal development of mature
oligodendrocytes in the postnatal and adult CNS (Table 1).
Figure 2 Summary scheme describing Cdk2-cyclin E interactions involved in cell cycle withdrawal and arrest in OPC. Compared to
proliferating OPCs (A), Cdk2 and cyclin E protein expression is not modified during reversible cell cycle arrest in G1 (B) but Cdk2-cyclin E complex
formation is impaired which causes a selective decrease in Cdk2 activity. However, in differentiated cells that had permanently withdrawn from
the cycle (C), protein levels, Cdk2-cyclin E complex formation and kinase activity are decreased compared to proliferating OPCs (A).
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mechanisms as described in the SVZ, only effective during
development and early postnatal, whereas requirement for
Cdk2 is less important in the adult due to the low prolif-
erative potential of adult OPC.
Cdk2 and cell cycle regulation in white matter disorders
Differential influence of Cdk2 on CNS myelination and
remyelination
The data described previously indicate that Cdk2 loss does
affect neither the number of white matter oligodendrocytes
and OPCs, nor their proliferation rate. However, since oli-
godendrocytes are responsible for myelin sheath synthesis
with each cell myelinating up to 40 independent axonal
segments [60], loss of Cdk2 could impact CNS myelin syn-
thesis. To explore this possibility, electron microscopy was
used but did not reveal any changes in axonal preservation,
in the number of myelinated axons, or differences in myelin
structure, after Cdk2 loss in the postnatal (P15) or adult
(P90) corpus callosum, since myelin compaction and g ratio
did not significantly differ in Cdk2−/− and WT mice [30].
In addition, Western blot quantification of MBP, one of the
most abundant CNS myelin protein [61], showed no differ-
ence in its levels between the two genotypes. Taken to-
gether, these data suggest that myelination during early
postnatal development is either Cdk2-independent or is ef-
ficiently compensated by other Cdks (Table 1).
Although some OPCs are still produced in the adult from
SVZ cells [10,22,62], decreased proliferation of these cellsunder physiological conditions in the absence of Cdk2 [39]
seems sufficient to maintain a normal density of oligo-
dendroglial cells in the corpus callosum. However, when
challenged with demyelination induced by LPC injection, a
process known to enhance proliferation of resident adult
OPCs and SVZ precursors [18,21], cell proliferation was
found to be reduced not only in the SVZ, but also in the le-
sion of Cdk2−/− mice [30] (Table 1). These alterations were
not an indirect consequence of axonal loss, as no obvious
alteration in axons and/or in axonal density, were observed
by electron microscopy. Since decreased proliferation spe-
cifically affected cells giving rise to oligodendrocytes, in-
cluding OPCs and type C cells of the SVZ, rather than
microglia and astrocytes, the consequences of altered prolif-
eration on OPC differentiation into oligodendrocytes were
investigated. Reduced proliferation was shown to be corre-
lated with enhanced cell cycle exit in adult OPCs of Cdk2
−/− mice, as compared to wild-type, as well as with
enhanced differentiation of adult OPCs into differentiated
CC1+ oligodendrocytes [30]. Interestingly, while NG2+
OPC densities were identical in the corpus callosum of
wild-type and Cdk2−/− non-injured mice, their reduced
proliferation at 7 days post injection (dpi) coincided with a
reduction in OPC density in Cdk2−/− mice, as compared
to wild-types. In contrast, CC1+ oligodendrocyte density
increased in Cdk2−/− mice 1 and 2 weeks later, a delay cor-
responding to the onset of remyelination and the oligo-
dendrocyte/myelin regeneration period in LPC lesions,
respectively. However, differences between Cdk2−/− mice
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repair was nearly accomplished [30]. Moreover, increased
cell cycle exit and oligodendrocyte differentiation in Cdk2
−/− mice had a direct impact on the number of remyeli-
nated axons, and on the extent of axonal remyelination, as
assessed by g ratio measurements in the lesion (Table 1).
The fact that remyelination in wild-type mice levelled with
that of Cdk2−/− mice at 21 dpi further underlines that
Cdk2 acts as a modulator rather than as an on-off switch of
the differentiation/remyelination process. These results are
consistent with previous in vitro findings showing that
Cdk2 loss decreased OPC proliferation [29] and promoted
lineage commitment of NG2-expressing progenitors in the
adult SVZ, and differentiation of adult neural progenitor
cells [39]. In view of these studies, Cdk2 appears as an in-
trinsic molecular mechanism that controls the timing of
oligodendrocyte differentiation in vivo. This conclusion is
supported by the fact that accelerated differentiation of
oligodendroglial cells in the absence of Cdk2 occurred also
in vitro [30].
Requirement for Cdk2 in adult OPCs could contribute
to a better understanding of remyelination failure in mul-
tiple sclerosis. In this inflammatory disease, endogenous
remyelination exists, but is not efficient in all lesions.
Among several possible hypotheses, dysregulation of OPC
proliferation has been proposed to play a role in remyeli-
nation failure, as demonstrated by reduced OPC prolifera-
tion in some lesions, although in others OPCs are
numerous, but appear unable to fully differentiate [63]. A
previous study also demonstrated that persistent CNS in-
flammation significantly altered cell kinetics of precursors
and stem cells in experimental autoimmune encephalomy-
elitis, a model of multiple sclerosis [64]. In view of the
above mentioned data [30,39], it would be of interest to
investigate whether Cdk2 expression is altered in MS and
could explain some of the default of remyelination
observed in MS lesions.
Influence of Cdk4 on PNS myelination and remyelination
Differential requirement of another Cdk, Cdk4, for mye-
lination/remyelination processes, was also described in the
PNS. Cell cycle function of Cdk4 is closely related to
Cdk2, as both Cdk2 and Cdk4 are activated by their regu-
latory proteins cyclin E and D, respectively, to sequentially
phosphorylate Rb. Although Cdk2−/− or Cdk4−/− mice
are viable, Cdk2−/−; Cdk4−/− double KO mice die in
utero around E15 [65]. Peripheral myelin formation
depends on axonal signals that tightly control proliferation
and differentiation of the associated Schwann cells [66].
Requirement for three different Cdks was analyzed in
Schwann cells using Cdk-deficient mice [67]. Mice lacking
Cdk4 showed a drastic decrease in the proliferation rate of
Schwann cells at postnatal days 2 and 5. However, prolif-
eration was unaffected at embryonic day 18 which couldbe due to compensatory mechanisms that are effective
during early development. In contrast, ablation of Cdk2
and Cdk6 had no significant influence on postnatal
Schwann cell proliferation. Taken together, these findings
indicate that postnatal Schwann cell proliferation is
uniquely controlled by Cdk4. Despite the lack of the post-
natal wave of Schwann cell proliferation, axons were nor-
mally myelinated in adult Cdk4-deficient sciatic nerves.
Following nerve injury, Schwann cells lacking Cdk4 were
unable to re-enter the cell cycle, while Schwann cells defi-
cient in Cdk2 or Cdk6 displayed proliferation rates com-
parable to controls [67]. No compensatory effects such as
elevated Cdk4 levels were observed in uninjured or
injured nerves of Cdk2- or Cdk6-deficient mice. So re-
quirement for Cdk4 in Schwann cells, as requirement for
Cdk2 in OPCs, seems to be different during developmen-
tal myelination compared to pathological event.
Differential role of Cdk2 in response to hypoxia
Periventricular white matter injury (PWMI) is a common
form of brain injury affecting preterm infants. A major
factor that predisposes to PWMI is hypoxia. Influences of
hypoxia on oligodendrocytes development were investi-
gated in vitro by maintaining purified cultures of OPCs at
21% O2 or hypoxia (1% or 4% O2) for up to 7 days [68].
1% O2 led to an increase in the proportion of myelin basic
protein (MBP)-positive oligodendrocytes after 1 week in
culture, and a decrease in the proportion of PDGFRα+
cells suggesting premature oligodendrocyte maturation.
Increased expression of the cell cycle regulatory proteins
p27Kip1 and phospho-Cdk1 was seen as well. Hypoxia
appears to interfere with the normal process of oligo-
dendrocyte differentiation by inducing premature OPC
maturation that may contribute to hypomyelination in the
developing hypoxic brain. The specific role of Cdk2 was
not investigated in these studies but giving the role of this
kinase in oligodendrocytes, we can suppose that the pre-
mature OPC maturation observed in response to
increased expression of p27Kip1 involves Cdk2 increased
inhibition and premature cell cycle exit. The role of Cdk2
in response to hypoxia has been studied in other cell types
and it appears that Cdk2 when associated with cyclin A, is
involved in hypoxia-induced apoptosis in cardiomyocytes
[69]. Indeed, some investigators have interpreted the rapid
induction of Cdk2 activity in cardiomyocytes as evidence
of post-mitotic cells reentering the cell cycle and undergo-
ing proliferative growth. However, an increasing amount
of data indicates that proteins classically thought to be
involved in cell cycle regulation also play a critical role in
the control of cell death, particularly through apoptotic
pathways. Numerous stimuli unrelated to cell cycle pro-
gression induce Cdk2 activity and subsequently apoptosis
such as irradiation [70], Tumor necrosis factor-α [71], Fas
[72], staurosporine [71], hypoxia [69,73], and ischemia
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activation of the mitotic processes does not occur even in
cells capable of proliferating [72]. Likewise, perturbations
of cell cycle progression, without affecting Cdk2 activity,
fail to block apoptosis [75] supporting the notion that
Cdk2 activation is not simply indicative of aberrant mi-
tosis but, instead, that Cdk2 plays a direct role in cell
death.
Cell cycle regulatory proteins involvement in
oligodendrocyte survival after ischemia
After transient focal cerebral ischemia, cyclin Dl and Cdk4
were selectively expressed in morphologically intact or
altered oligodendrocytes and neurons localized to the is-
chemic tissue. Apoptotic cells were not immunoreactive
to these proteins at 46 hours of reperfusion after 2 hours
of middle cerebral artery occlusion (I/R injury). However,
cyclin D1 and Cdk4 induction is not involved in the onset
of astrocyte and microglial cell proliferation in response to
ischemia [76]. p21 protein levels in oligodendrocytes and
neurons were also found to gradually increase to 250%
and 140% of contralateral levels in areas bordering the in-
farct core up to 6 h following middle cerebral artery occlu-
sion whereas a low level of constitutively p21 was found
in nuclei of these cells. In contrast, p53, p27 and cyclin E
levels decrease in the infarct core and border areas with
time after middle cerebral artery occlusion. The selective
up-regulation of p21 in the border zone of a focal ische-
mic infarct indicates its involvement in an adaptive re-
sponse to ischemic injury [77]. The potential contribution
of Cdk2 to oligodendrocyte survival in response to cere-
bral ischemia was not investigated in these studies but was
observed in other cell type. Indeed, myocardial ischemia
activates Cdk2, resulting in the phosphorylation and in-
activation of Rb. Blocking Cdk2 activity reduces apoptosis
in cultured cardiac myocytes. Genetic or pharmacological
inhibition of Cdk2 activity in vivo during I/R injury led to
a 36% reduction in infarct size, when compared to control
mice, associated with a reduction in apoptotic myocytes
[78]. These data suggest that Cdk2 signaling pathways are
critical regulators of cardiac I/R injury in vivo whereas the
loss of Cdk2 was shown to have no effect on apoptosis
consecutive to focal demyelination in the adult brain [30]
confirming the cell specific role of Cdk2.
Cell cycle activation following spinal cord injury
Traumatic spinal cord injury (SCI) evokes a complex cascade
of events with initial mechanical damage leading to second-
ary injury processes that contribute to further tissue loss and
functional impairment. Growing evidence suggests that the
cell cycle is activated following SCI [79-81]. Expression of
key cell cycle activator genes, such as cyclin D, Cdk4 and Rb
were up-regulated at the early time points (i.e., 4 h and 24 h)
after SCI [82]. Upregulation of cell cycle proteins after injuryappears to contribute not only to apoptotic cell death of
postmitotic cells, including neurons and oligodendrocytes,
but also to posttraumatic gliosis and microglial activation. In-
hibition of key cell cycle regulatory pathways reduces injury-
induced cell death, as well as microglial and astroglial prolif-
eration both in vitro and in vivo. Treatment with cell cycle
pharmacological or endogenous inhibitors like p21 in rodent
SCI models prevents neuronal cell death and reduces inflam-
mation, as well as the surrounding glial scar, resulting in
markedly reduced lesion volumes and improved motor re-
covery [82]. In a recent study, Cdk2 and cyclin H protein ex-
pression and their association were demonstrated to be
increased in proliferating microglia and astrocytes in a rat
spinal cord contusion model [83] whereas loss of Cdk2 did
not affect proliferation of these cells in response to focal de-
myelination of the adult brain [30]. Cyclin H regulates cell
cycle transitions by forming trimeric Cdk-activating kinase
(CAK) complex with Cdk7 and MAT1 that phosphorylates
and activates Cdk2. So Cdk2 and cyclin H may play a prolif-
erative role in spinal cord injury.
Conclusion
In the adult CNS, requirement for Cdk2 appears specific to
oligodendrocyte cell type as Cdk2 loss appears to affect only
cells giving rise to this lineage. This could explain the differ-
ential requirement for Cdk2 in adult germinative regions:
although Cdk2 is critical for proliferation and self-renewal
of neural progenitor cells in the adult SVZ, it is dispensable
for adult hippocampal neurogenesis. Lower Cdk2 expres-
sion and loss of compensation mechanisms in the adult
could contribute to the progressive decline of proliferation
potential and self-renewal of SVZ cells with aging and to
their lower regeneration ability. Cdk2 also controls OPC
cell cycle progression and is downregulated in adult OPC
characterized with low proliferative activity. However, it is
not required for normal development of myelinating oligo-
dendrocytes and myelination in the postnatal and adult
CNS probably due to compensatory mechanisms only ef-
fective during development and early postnatal life. Indeed,
loss of Cdk2 has consequences on adult remyelination with
decreased OPC proliferation but accelerated differentiation
and repair. So, requirement for Cdk2 in OPCs seems to dif-
fer during developmental myelination compared to patho-
logical events and this discrepancy could be of relevance for
the comprehension of pathological mechanisms and the
elaboration of therapeutic strategies specifically targeted to
OPCs. Inhibitors of Cdk2 are developed and applied in can-
cer therapy. Whether such inhibitors would promote
remyelination in animal models and whether Cdk2 plays a
role in remyelination failure in MS or other myelin disor-
ders remains open questions and deserve further attention.
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